https://www.selleckchem.com/products/ykl5-124.html
68, 95% CI 2.02-6.7 and PFS (HR 3.69, 95% CI 2.09-6.5. In a landmark analysis at day 200, prolonged immunoparesis was associated with reduced OS (HR 3.22, 95% CI 1.14-9.11). Allogeneic stem cell transplantation offers an additional treatment element that may lead to long-term remission in selected patients with poor prognosis, probably exploiting graft-versus-myeloma effects. Immunoparesis could potentially serve as an indicator for impaired survival following allogeneic transplantation, an observation to be further studied prospec
Curtir
Comentario
Compartilhar
